CeMM-Forschungszentrum für Molekulare Medizin GmbH
发明人:
Jin Li,Stefan Kubicek
申请号:
US15303170
公开号:
US09999621B2
申请日:
2015.04.09
申请国别(地区):
US
年份:
2018
代理人:
摘要:
The invention refers to BTBD9 binders and gephyrin binders for medical use and in particular an artemisinin compound of general formula I for use in the treatment of a diabetes patient, as well as a method of identifying suitable lead candidates.